Psychiatry & Neurology, Sleep Medicine · Bloomington, MN
NPI
1205004249
Since 2008
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3601 Minnesota Dr Ste 200
Bloomington, MN, 55435
Phone (612) 879-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
5,958 services
Medicare patients, 2024
350
Average age 70
Drug cost, 2024
$647K
2,396 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Damergis Jr. was code 99215 (office e&m - established), 194 times for 171 patients. In total John A Damergis Jr. billed 5,958 services in 39 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 194 | 171 | $129.16 | $25K |
| 99214 Office E&M - Established | Office | 143 | 133 | $89.75 | $13K |
| 99204 Office E&M - New | Office | 36 | 36 | $116.11 | $4,180 |
| 95806 Sleep Study | Office | 35 | 34 | $74.32 | $2,601 |
| 95810 Sleep Study | Office | 35 | 33 | $479.86 | $17K |
| 95811 Sleep Study | Office | 33 | 32 | $494.53 | $16K |
| 95803 Sleep Study | Office | 11 | 11 | $99.06 | $1,090 |
By year: 2022 $119K for 2,761 services; 2023 $92K for 1,808 services; 2024 $179K for 5,958 services.
Medicare prescription drug claims, 2024
In 2024, the drug John A Damergis Jr. prescribed most often to Medicare patients was Gabapentin, with 305 prescriptions and refills. In total John A Damergis Jr. wrote 2,396 Medicare prescriptions that cost $647K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 305 | 757 | 93 | $5,882 |
| Trazodone Hcl Generic | 167 | 384 | 49 | $2,845 |
| Clonazepam Generic | 157 | 277 | 40 | $1,478 |
| Modafinil Generic | 150 | 308 | 52 | $17K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 146 | 350 | 39 | $3,325 |
| Belsomra Suvorexant | 117 | 199 | 37 | $83K |
| Pregabalin Generic | 113 | 207 | 32 | $4,425 |
| Methylphenidate Hcl Generic | 91 | 165 | 30 | $4,131 |
| Zaleplon Generic | 76 | 137 | 25 | $1,629 |
| Ropinirole Hcl Generic | 69 | 163 | 20 | $1,367 |
| Donepezil Hcl Generic | 68 | 160 | 18 | $1,196 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 66 | 93 | 14 | $3,979 |
| Armodafinil Generic | 65 | 111 | 14 | $4,449 |
| Eszopiclone Generic | 55 | 141 | 15 | $1,549 |
| Temazepam Generic | 48 | 78 | 15 | $690 |
Brand drugs: 248 claims; generic drugs: 2,148 claims; opioid claims: 70.
Money and other things of value reported by the companies
No payments from drug or medical device companies to John A Damergis Jr. were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.